Skip to content

Effectiveness and Safety Study of LAP-BAND Treatment for Obese Adolescents

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00447590
Enrollment
153
Registered
2007-03-15
Start date
2007-03-31
Completion date
2013-06-30
Last updated
2014-10-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Morbid Obesity

Brief summary

The purpose of this study is to determine whether the LAP-BAND system is safe and effective in morbidly obese adolescents.

Detailed description

The primary objective of this study was to evaluate the safety and effectiveness of the LAP-BAND System in a morbidly obese adolescent population, ages 14 to 17 years. The secondary objectives were to assess associated changes from baseline in obesity-related comorbidities as well as psychosocial functioning.

Interventions

Restriction of food intake

Sponsors

Apollo Endosurgery, Inc.
Lead SponsorINDUSTRY

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
14 Years to 17 Years
Healthy volunteers
No

Inclusion criteria

* Between the ages of 14 and 17 at the time of enrollment * Have a BMI ≥ 40 kg/m2 (with or without obesity-related co-morbid conditions) or BMI ≥ 35 kg/m2 with one or more severe co-morbid conditions * Have a history of obesity for at least 2 years and have failed more conservative weight-reduction alternatives, such as supervised diet, exercise and behavior modification programs

Exclusion criteria

* Family or subject history of congenital or acquired anomalies of the gastrointestinal tract * Severe cardiopulmonary or other serious or uncontrolled organic disease * Severe coagulopathy; hepatic insufficiency or cirrhosis * History of bariatric, gastric, or esophageal surgery * History of intestinal obstruction or adhesive peritonitis * History of esophageal dysmotility disorders * Type I diabetes

Design outcomes

Primary

MeasureTime frameDescription
Percent of Subjects Who Attain Clinically Successful Weight Loss of ≥30% Excess Weight Loss (EWL) at 1 Year Post LAP-BAND Implantation.1 yearPercent Excess Weight Loss was defined as Weight Loss divided by Excess Weight multiplied by 100. Excess Weight = baseline weight - ideal weight, where Ideal weight was determined using the 85th percentile on the Centers for Disease Control (CDC) Growth Charts for children and adolescents ages 2 to 20 years.

Secondary

MeasureTime frameDescription
Subject Excess Weight Loss Throughout the StudyBaseline to 5 YearsExcess Weight Loss was examined over the 5 year period post LAP-BAND implantation. Excess Weight Loss was defined as Weight Loss divided by Excess Weight multiplied by 100.
Subject Percent Excess BMI LossBaseline to 5 YearsSubject Percent Excess BMI Loss was examined at 5 years post LAP-BAND placement.
Change in Subjects' Comorbid ConditionsBaseline to 5 YearsThe change from baseline to year five in subjects' comorbid conditions of Type II Diabetes, Dyslipidemia, and Hypertension. Change as reported below indicates the condition resolved.
Change in Quality of Life Using the Beck Depression Inventory II (BDI)Baseline to 5 YearsQuality of life was examined using the Beck Depression Inventory II (BDI) questionnaire, which scores on a range from 0 (best) to 63 (worst). The change in subjects' BDI II score was assessed from baseline to 5 years.
Change in Quality of Life Using Impact of Weight on Quality of Life (IWQOL) Kids QuestionnaireBaseline to 5 YearsQuality of life was examined using the Impact of Weight on Quality of Life (IWQOL) Kids questionnaire, which has a score range from 0(worst) to 100(best). The change in subjects' IWQOL Kids score was assessed from baseline to 5 years.

Countries

United States

Participant flow

Pre-assignment details

174 participants were enrolled in the study, where enrollment was defined as signing the informed consent form. 21 participants were not implanted after signing the informed consent. 153 participants were treated with the LAP-BAND.

Participants by arm

ArmCount
LAP-BAND
All subjects who received the LAP-BAND System.
153
Total153

Withdrawals & dropouts

PeriodReasonFG000
Overall StudyBand Removed/Eroded/Other Follow-Up Loss10
Overall StudyLost to Follow-up24
Overall StudyWithdrawal by Subject26

Baseline characteristics

CharacteristicLAP-BAND
Age, Continuous15.8 years
Age, Customized
Age 14
25 participants
Age, Customized
Age 15
33 participants
Age, Customized
Age 16
47 participants
Age, Customized
Age 17
46 participants
Age, Customized
Age 18
2 participants
Body Mass Index (BMI)48.5 kg/m2
Excess Weight152.3 pounds (lb)
Race/Ethnicity, Customized
Black/African-American
37 participants
Race/Ethnicity, Customized
Caucasian
102 participants
Race/Ethnicity, Customized
Hispanic/Latino
10 participants
Race/Ethnicity, Customized
Other
4 participants
Sex: Female, Male
Female
103 Participants
Sex: Female, Male
Male
50 Participants

Adverse events

Event typeEG000
affected / at risk
deaths
Total, all-cause mortality
— / —
other
Total, other adverse events
133 / 153
serious
Total, serious adverse events
20 / 153

Outcome results

Primary

Percent of Subjects Who Attain Clinically Successful Weight Loss of ≥30% Excess Weight Loss (EWL) at 1 Year Post LAP-BAND Implantation.

Percent Excess Weight Loss was defined as Weight Loss divided by Excess Weight multiplied by 100. Excess Weight = baseline weight - ideal weight, where Ideal weight was determined using the 85th percentile on the Centers for Disease Control (CDC) Growth Charts for children and adolescents ages 2 to 20 years.

Time frame: 1 year

Population: Intent to treat (ITT) population with imputation at month 12 (ITT population consisted of participants treated with the LAP-BAND).

ArmMeasureValue (NUMBER)
LAP-BANDPercent of Subjects Who Attain Clinically Successful Weight Loss of ≥30% Excess Weight Loss (EWL) at 1 Year Post LAP-BAND Implantation.49.7 percentage of participants
Comparison: p-Value is from a 2-sided exact binomial test to test the null hypothesis that 30% of subjects have at least 30% EWL.p-value: <0.00012-sided Exact Binomial Test
Secondary

Change in Quality of Life Using Impact of Weight on Quality of Life (IWQOL) Kids Questionnaire

Quality of life was examined using the Impact of Weight on Quality of Life (IWQOL) Kids questionnaire, which has a score range from 0(worst) to 100(best). The change in subjects' IWQOL Kids score was assessed from baseline to 5 years.

Time frame: Baseline to 5 Years

Population: Participants who completed the IWQOL Kids questionnaire through month 60 (year 5).

ArmMeasureValue (MEAN)
LAP-BANDChange in Quality of Life Using Impact of Weight on Quality of Life (IWQOL) Kids Questionnaire18.0 units on IWQOL Kids scale
Secondary

Change in Quality of Life Using the Beck Depression Inventory II (BDI)

Quality of life was examined using the Beck Depression Inventory II (BDI) questionnaire, which scores on a range from 0 (best) to 63 (worst). The change in subjects' BDI II score was assessed from baseline to 5 years.

Time frame: Baseline to 5 Years

Population: Participants who completed the BDI II questionnaire through month 60

ArmMeasureValue (MEAN)
LAP-BANDChange in Quality of Life Using the Beck Depression Inventory II (BDI)-1.0 units on BDI scale
Secondary

Change in Subjects' Comorbid Conditions

The change from baseline to year five in subjects' comorbid conditions of Type II Diabetes, Dyslipidemia, and Hypertension. Change as reported below indicates the condition resolved.

Time frame: Baseline to 5 Years

Population: Subjects who had a specific comorbid condition at baseline (Diabetes n=9, Dyslipidemia n=39, Hypertension n=22)

ArmMeasureGroupValue (NUMBER)
LAP-BANDChange in Subjects' Comorbid ConditionsDiabetes Type II (n=9)3 participants whose condition resolved
LAP-BANDChange in Subjects' Comorbid ConditionsDyslipidemia (n=39)14 participants whose condition resolved
LAP-BANDChange in Subjects' Comorbid ConditionsHypertension (n=22)7 participants whose condition resolved
Secondary

Subject Excess Weight Loss Throughout the Study

Excess Weight Loss was examined over the 5 year period post LAP-BAND implantation. Excess Weight Loss was defined as Weight Loss divided by Excess Weight multiplied by 100.

Time frame: Baseline to 5 Years

Population: Intent to treat (ITT) population with imputation at month 60

ArmMeasureValue (MEAN)Dispersion
LAP-BANDSubject Excess Weight Loss Throughout the Study27.0 %EWLStandard Deviation 45.46
Secondary

Subject Percent Excess BMI Loss

Subject Percent Excess BMI Loss was examined at 5 years post LAP-BAND placement.

Time frame: Baseline to 5 Years

Population: Intent to treat (ITT) population with imputation at month 60

ArmMeasureValue (MEAN)Dispersion
LAP-BANDSubject Percent Excess BMI Loss-6.0 kg/m295% Confidence Interval 11.12

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026